La Jolla Pharmaceutical Co.

NASDAQ:LJPC  
3.89
-0.04 (-1.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)105.39M
Current PEN/A
Forward PE 7.78
2yr Forward PE 12.97
See more stats
Estimates Current Quarter
Revenue$33.15 Million
Adjusted EPS$0.56
See more estimates
10-Day MA$4.11
50-Day MA$4.52
200-Day MA$4.58
See more pivots

La Jolla Pharmaceutical Co. Stock, NASDAQ:LJPC

201 Jones Road, Suite 400, Waltham, Massachusetts 02451
United States of America
Phone: +1.617.715.3600
Number of Employees: 59

Description

La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA.